News
We take pride in our achievements and want to share our successes with you.
Updates on our latest news on IBsolvMIR will be added as soon as it’s available.

NEWS

24 July 2018
TIKOMED is looking for an experienced Project Leader
We are looking for you who are passionate, skilled and with strong track record and…
Read More
5 June 2018
Anders Kristensson appointed CEO of TikoMed
Viken – 18th June 2018 TikoMed, a privately-held biopharmaceutical company today announced the appointment of…
Read More
22 April 2018
TIKOMED IS INTERVIEWED AT BIOSPRING ABOUT IBSOLVMIR FOR IMPROVED CELL-THERAPIES BY MIKE WARD
TikoMeds promising Phase 2 project for more efficient cell-therapies was presented at BioEurope Spring in…
Read More
22 March 2018
TIKOMED PRESENTS IBSOLVMIR AT BIO EUROPE
IBsolvMIR is TikoMed’s original project addressed at alleviating the ”Instant Blood Mediated Inflammatory Reaction” that…
Read More

SUBSCRIBE